ATE97495T1 - Bestimmung mit affinitaetssubstanzen und hplcschritt. - Google Patents

Bestimmung mit affinitaetssubstanzen und hplcschritt.

Info

Publication number
ATE97495T1
ATE97495T1 AT89107393T AT89107393T ATE97495T1 AT E97495 T1 ATE97495 T1 AT E97495T1 AT 89107393 T AT89107393 T AT 89107393T AT 89107393 T AT89107393 T AT 89107393T AT E97495 T1 ATE97495 T1 AT E97495T1
Authority
AT
Austria
Prior art keywords
determination
affinity substances
hplc step
affinity
analyte
Prior art date
Application number
AT89107393T
Other languages
English (en)
Inventor
Shinji Satomura
Kenji Nakamura
Tokuji Ikenaka
Kaoru Omichi
Original Assignee
Wako Pure Chem Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wako Pure Chem Ind Ltd filed Critical Wako Pure Chem Ind Ltd
Application granted granted Critical
Publication of ATE97495T1 publication Critical patent/ATE97495T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N30/06—Preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/971—Capture of complex after antigen-antibody reaction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/812—Infectious mononucleosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Peptides Or Proteins (AREA)
AT89107393T 1988-04-25 1989-04-24 Bestimmung mit affinitaetssubstanzen und hplcschritt. ATE97495T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10179888 1988-04-25
EP89107393A EP0357869B1 (de) 1988-04-25 1989-04-24 Bestimmung mit Affinitätssubstanzen und HPLC-Schritt

Publications (1)

Publication Number Publication Date
ATE97495T1 true ATE97495T1 (de) 1993-12-15

Family

ID=14310167

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89107393T ATE97495T1 (de) 1988-04-25 1989-04-24 Bestimmung mit affinitaetssubstanzen und hplcschritt.

Country Status (5)

Country Link
US (1) US5545530A (de)
EP (1) EP0357869B1 (de)
JP (1) JPH0734015B2 (de)
AT (1) ATE97495T1 (de)
DE (1) DE68910758T2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE131933T1 (de) * 1990-01-09 1996-01-15 Wako Pure Chem Ind Ltd Verfahren zur abtrennung und messung von spurbestandteilen
JP2994739B2 (ja) * 1990-11-29 1999-12-27 和光純薬工業株式会社 微量成分の迅速測定方法
US5571729A (en) * 1992-06-17 1996-11-05 Wako Pure Chemical Industries, Ltd. Process for separating complex
DE69422692T2 (de) * 1993-11-16 2000-07-06 Wako Pure Chem Ind Ltd Verfahren zum Trennen und Messen von Glykoprotein
CA2181109A1 (en) 1995-07-18 1997-01-19 Nobuko Imajo Polypeptide and process for measuring living body components using the same
EP0794434B1 (de) * 1995-09-22 2005-04-06 Asahi Denka Kogyo Kabushiki Kaisha Verfahren zur analyse von allergenen
US6005256A (en) * 1998-02-12 1999-12-21 Raytheon Company Method and apparatus for performing cell analysis based on simultaneous multiple marker emissions from neoplasia (CASMMEN)
US6471968B1 (en) 2000-05-12 2002-10-29 Regents Of The University Of Michigan Multifunctional nanodevice platform
EP1376126B1 (de) * 2001-04-04 2010-05-05 Wako Pure Chemical Industries, Ltd. Elektrophorese mit doppelstrang-dna-marker
US7442313B2 (en) * 2003-08-27 2008-10-28 Thinkvillage-Kerfoot, Llc Environmental remediation method and system
US7569140B2 (en) * 2005-11-10 2009-08-04 Thinkvillage-Kerfoot, Llc Directional spargewell system
US7621696B2 (en) * 2006-07-12 2009-11-24 Thinkvillage-Kerfoot, Llc Directional microporous diffuser and directional sparging
US8771507B2 (en) 2003-12-24 2014-07-08 Thinkvillage-Kerfoot, Llc Directional microporous diffuser and directional sparging
WO2005115477A2 (en) 2004-04-13 2005-12-08 Quintessence Biosciences, Inc. Non-natural ribonuclease conjugates as cytotoxic agents
CA2578205A1 (en) * 2004-08-25 2006-03-30 The Regents Of The University Of Michigan Partially acetylated dendrimers and related methods of use
US20070041934A1 (en) * 2005-08-12 2007-02-22 Regents Of The University Of Michigan Dendrimer based compositions and methods of using the same
JP2009541333A (ja) 2006-06-23 2009-11-26 クインテセンス バイオサイエンシーズ インコーポレーティッド 修飾リボヌクレアーゼ
EP2049151A4 (de) * 2006-07-17 2010-03-24 Quintessence Biosciences Inc Verfahren und zusammensetzungen zur behandlung von krebs
US20090088376A1 (en) * 2007-04-19 2009-04-02 The Regents Of The University Of Michigan Dendrimer based compositions and methods of using the same
US8916135B2 (en) * 2007-08-22 2014-12-23 Colorado School Of Mines Lanthanide nanoparticle conjugates and uses thereof
US8697062B2 (en) * 2007-10-08 2014-04-15 Quintessence Biosciences, Inc. Compositions and methods for ribonuclease-based therapeutics
US8252834B2 (en) 2008-03-12 2012-08-28 The Regents Of The University Of Michigan Dendrimer conjugates
WO2010096464A1 (en) 2009-02-18 2010-08-26 Boyes Stephen G Gold/lanthanide nanoparticle conjugates and uses thereof
WO2010039861A2 (en) 2008-09-30 2010-04-08 The Regents Of The University Of Michigan Dendrimer conjugates
EP2334695B1 (de) 2008-10-01 2015-12-23 Quintessence Biosciences, Inc. Therapeutische ribonukleasen
BRPI0920552A2 (pt) 2008-10-09 2019-09-24 Univ Northeastern nanosistemas poliméricos auto-organizáveis multifuncionais
US9017644B2 (en) 2008-11-07 2015-04-28 The Regents Of The University Of Michigan Methods of treating autoimmune disorders and/or inflammatory disorders
WO2011059609A2 (en) 2009-10-13 2011-05-19 The Regents Of The University Of Michigan Dendrimer compositions and methods of synthesis
WO2011059586A2 (en) 2009-10-30 2011-05-19 The Regents Of The University Of Michigan Multifunctional small molecules
EP2630495B1 (de) * 2010-10-18 2017-02-08 Nestec S.A. Verfahren zur bestimmung von gegen medikamente gerichtete antikörperisotypen
WO2013085718A1 (en) 2011-12-08 2013-06-13 The Regents Of The University Of Michigan Multifunctional small molecules

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL42105A (en) * 1973-04-25 1976-08-31 Yissum Res Dev Co Process for determination of triiodothyronine
IL51224A (en) * 1976-11-19 1979-09-30 Ames Yissum Ltd Assay method for the quanititative determination of a hapten in aqueous solution
US4145406A (en) * 1977-04-11 1979-03-20 Miles Laboratories, Inc. Specific binding - adsorbent assay method and test means
US4235869A (en) * 1978-05-16 1980-11-25 Syva Company Assay employing a labeled Fab-fragment ligand complex
US4371515A (en) * 1978-12-26 1983-02-01 E-Y Laboratories, Inc. Method for forming an isolated lectin-immunological conjugate
US4347058A (en) * 1980-09-15 1982-08-31 Beckman Instruments, Inc. Thyroid polarization fluoroimmunoassay
EP0073593A1 (de) * 1981-09-01 1983-03-09 E.I. Du Pont De Nemours And Company Grössendiskriminierende heterogene Immunzusammensetzung
US4496654A (en) * 1983-04-08 1985-01-29 Quidel Detection of HCG with solid phase support having avidin coating
DE3342627A1 (de) * 1983-11-25 1985-06-05 Boehringer Mannheim Gmbh, 6800 Mannheim Immunchemischer schnelltest
JPH0610678B2 (ja) * 1984-11-05 1994-02-09 オリンパス光学工業株式会社 免疫学的分析方法
JPS61120058A (ja) * 1984-11-16 1986-06-07 Hitachi Ltd 目的成分の分析方法及びその装置
US4670381A (en) * 1985-07-19 1987-06-02 Eastman Kodak Company Heterogeneous immunoassay utilizing horizontal separation in an analytical element

Also Published As

Publication number Publication date
EP0357869A1 (de) 1990-03-14
JPH0228557A (ja) 1990-01-30
JPH0734015B2 (ja) 1995-04-12
DE68910758D1 (de) 1993-12-23
US5545530A (en) 1996-08-13
DE68910758T2 (de) 1994-05-26
EP0357869B1 (de) 1993-11-18

Similar Documents

Publication Publication Date Title
ATE97495T1 (de) Bestimmung mit affinitaetssubstanzen und hplcschritt.
FI904534A0 (fi) Foerfarande och anordning foer amperometrisk diagnosanalys.
HU902407D0 (en) Process and device for determining components of fluid sample
EP0417305A4 (en) Analyzer of liquid sample and analyzing method of liquid sample using said analyzer
DE69330067T2 (de) Analytische testvorrichtung einschliesslich negativ- und positivkontrolle
FI891012A (fi) Menetelmä ja väline immuunikokeissa esiintyvien häiriötekijöiden kompensoimiseksi
JPS57200862A (en) Mutilayer analysis element utilizing unique binding reaction
DK95792D0 (da) Sensor til non-invasiv, in vivo bestemmelse af en analyt og blodgennemstroemning
ATE207542T1 (de) Testvorrichtung mit einem stabilen kopplungsfarbstoff zur bestimmung von analyten
DK0618449T3 (da) Fremgangsmåde til bestemmelse af hæmoglobin-additionsprodukter
ES489644A0 (es) Un metodo de determinar la cantidad o concentracion de un analito en una muestra
ATE100150T1 (de) Verfahren zur bestimmung von physiologisch wirksamen substanzen.
DK492185D0 (da) Screeningtest for omvendt-transkriptaseholdig virus
DE69029556D1 (de) Trockenes analytisches Element zur quantitativen Analyse von in Vollblut enthaltenen Analyten
EP0349263A3 (en) Analyzing means and method
AU1245188A (en) Analyte detection in particulate-containing samples
CA2283154A1 (en) Method and apparatus for measurement of blood substitutes
EP0159727A3 (en) Analytical element for analysis of whole blood sample
EP0230934A3 (de) Monoklonaler Antikörper, Verfahren zur Messung eines glucosylierten Proteins unter Verwendung von diesem monoklonalen Antikörper, und Kit dafür
ATE77700T1 (de) Immunkomplextestverfahren.
EP0329458A3 (de) Verfahren und Gerät zur Messung von Analyten
GR3018568T3 (en) Process for separating and measuring trace components
EP0418482A3 (en) Reagent for the detection and determination of bilirubin in the urine
DE69419936D1 (de) Nachweisverfahren und vorrichtung dafür
EP0217768A3 (en) Method and compositions for heparin assays

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee